Announcements

23 January 2024
Acknowledgment of the Reviewers of Drugs and Drug Candidates in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Drugs and Drug Candidates. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Drugs and Drug Candidates received 217 review reports, from 201 reviewers. This past year, we worked with reviewers from 41 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Drugs and Drug Candidates family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

Adam Matkowski Mariana Spetea
Adina Gavrila Massimiliano Ammirabile
Alan Richardson Matthias Müller
Alberto Ongaro Michael Diamantidis
Aleksandra Józefczyk Mina Yekani
Ana Ledesma Mohsen Korani
Aneta Ostróżka-Cieślik Nancy Weiland-Bräuer
Angela Bisio Neeraj Thakur
Anik Karan Nicola D'Antona
Anna Szakiel Nikolay Polyakov
Chiara Suffritti Nobuaki Yasuo
Claudia Giovagnoli-Vicuña Ovidiu-Cristian Oprea
Dakir Mohamed Peter Timmins
Daniil Olennikov Rahul Mandal
Gábor Kökény Saad Salman
George Mihai Nitulescu Sandeep Kumar Reddy Adena
Grzegorz Bartosz Sathish Thirunavukkarasu
Hadia Almahli Sébastien Fortin
Inga Kwiecien Sekelwa Cosa
Ioana Ionut Siriporn Okonogi
Ivana Škrlec Socorro Espuelas
Izabela Irska Sophia Borisevich
Jacopo Junio Valerio Branca Sotirios N. Kiokias
João Pedro Silva Steven Shave
Josué Juarez Taha Mehany
Jozsef Dudas Vangelis Daskalakis
Kamil J. Kuder Vijay Singh Gondil
Kandhasamy Sowndhararajan Vikram Dalal
Kristina Kantminienė Visnja Stepanic
Liliana Vargas-Murga Wing Wong
Łukasz Szeleszczuk Xin Li
M. Matilde Marques Xinpeng Cheng
Mahrous Abdelbasset Ibrahim Zhonglei Wang
Małgorzata Jarończyk Zhong-Ru Xie

More News...
Back to TopTop